In a new ACT video interview, Shanthi Sivendran, MD, MSCR, MBA, senior vice president for cancer care support at the American ...
The FDA has approved the first GLP-1 pill for weight loss and it's expected in pharmacies in the coming weeks. Dr. Holly ...
Nick Shirley, who exposed what he alleges are bogus childcare centers stealing government money in Minnesota, defended his ...
With Americans focused on getting fit in the new year, a groundbreaking new option is set to shift the weight loss landscape ...
For Somalis in Greater Minnesota, distance from enhanced ICE raids in the Twin Cities hasn’t provided much solace.
Cleaning your ear out and removing ear wax might sound like an innocent act of self care, but one expert is sounding the ...
The top 10 PharmTech videos of the year cover advanced therapies, high-concentration biologics, major mergers and ...
Funding uncertainty, legal and political pressures, trade policy shifts, site collaboration strategies, and leadership perspectives were central themes across Applied Clinical Trials’ most-watched ...
Investor's Business Daily on MSN
Axsome Therapeutics stock jumps after FDA grants priority review for Alzheimer's agitation drug
Axsome stock jumped Wednesday after the biotech firm said its Alzheimer's disease agitation drug will get a priority review.
Going into the fourth year without federal abortion rights protections, groups that helped overturn Roe v. Wade are focused ...
Only two men can tell us if Elon Musk and Trump are truly, as of December 2025, “friends.” But the formal definition I used ...
E! Online on MSN
Oprah Reveals Use of GLP-1 Medications Led to Sobriety
Oprah Winfrey detailed that in addition to weight loss and renewed energy, her use of GLP-1 medications for weight loss also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results